DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY

The Ohio State University

Status and phase

Enrolling

Phase 2

Conditions

Cancer of the Breast

Chemotherapy-induced Neuropathy

Treatments

Behavioral: Tango

Study type

Interventional

Funder types

Other

NIH

Identifiers

NCT06749210

OSU-24277 (Other Identifier)

R01AG084676 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Up to 80% of breast cancer survivors experience chemotherapy-induced neuropathy that impairs quality of life and increases fall risk long into survivorship, yet treatment options for neuropathy remain limited. The successful treatment will target neurophysiologic mechanisms for restoring function while addressing patient-reported symptoms and participation in treatment. Toward this end, the investigators propose to study a noninvasive, social sensorimotor intervention - Adapted Argentine Tango - which targets motor control restoration, symptom alleviation, and treatment participation in concert.

Full description

This study will investigate a noninvasive, social, sensorimotor intervention which targets motor control restoration, symptom alleviation, and treatment participation in concert: partnered Adapted Argentine Tango (Tango). This project will expand the investigators' pilot work (R21-AG068831) into a multicenter clinical trial designed to investigate the effect of social dance on sensory relief, functional restoration, and key mechanisms of action among a diverse cohort of BC survivors suffering from chronic chemotherapy-induced sensorimotor deficits.

Enrollment

140 estimated patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Breast Cancer (BC) diagnosis of Stage I-IV including metastatic disease
completed taxane-based chemotherapy for BC at least 3 months ago (no limit on how long ago)
symptomatic for chemotherapy-induced neuropathy (self-report)
postural control score that indicates potential fall-risk
able to understand and comply with directions associated with testing and study treatments

Exclusion criteria

pre-existing vestibular dysfunction
poorly controlled diabetes (hgA1C>=8)
non-ambulatory (assistive and prosthetic devices allowed)
hearing impairment resulting in less than 10% hearing bilaterally
contraindication to participate in the experimental physical activity per the treating oncologist due to additional condition (e.g., herniated disc, unstable bone metastases)
currently in activity-based therapy (e.g., physical therapy, occupational therapy). May enroll if still meet eligibility criteria once activity-based therapy is complete.